Product image of Helituspan (Dry Extract Of Hederae Folium (5-7.5:1), Extraction Solvent: Ethanol 30% (M/M)) supplied by GNH India

Helituspan

Active Ingredient:
Dry Extract Of Hederae Folium (5-7.5:1), Extraction Solvent: Ethanol 30% (M/M)
Origin:
EU

Helituspan (Dry Extract Of Hederae Folium (5-7.5:1), Extraction Solvent: Ethanol 30% (M/M))

Helituspan is a pharmaceutical product that contains a dry extract of Hederae Folium (ivy leaf) standardized at a 5‑7.5:1 ratio and prepared with 30 % ethanol (m/m) as the extraction solvent. It is intended for oral administration and is marketed within the European Union. The product’s strength and dosage form are not specified in the available data, and it is listed without a defined prescription status.

Manufacturer / TM Owner

Sopharma Ad

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Helituspan contains ivy leaf extract, which has been studied for its potential role in respiratory support. Clinical and traditional use suggest the following applications:

  • Adjunctive support for occasional, non‑productive cough in adults.
  • Complementary use in mild upper‑respiratory tract irritation.
  • Inclusion in herbal formulations aimed at facilitating expectoration.
  • Supportive care for throat discomfort associated with dry cough.
  • Possible use as part of a multi‑herb product for bronchial soothing.

Side Effects

Reported adverse effects of ivy leaf extract vary in frequency and severity. The following categories summarize observations from clinical and post‑marketing sources.

Common

  • Mild gastrointestinal discomfort such as nausea or abdominal cramps.
  • Transient skin rash or pruritus.
  • Mild headache.
  • Dizziness.

Serious

  • Allergic anaphylactic reaction.
  • Severe bronchospasm in sensitive individuals.
  • Rare hepatic enzyme elevation.

Precautions & Warnings

When considering Helituspan, several precautionary measures should be observed to minimize risk.

  • Do not use in individuals with known hypersensitivity to ivy or related plants.
  • Avoid use in children under 12 years unless advised by a healthcare professional.
  • Caution in patients with asthma or chronic obstructive pulmonary disease.
  • Pregnancy and lactation status is not established; consult a clinician.
  • Monitor for gastrointestinal upset during initial use.
  • Discontinue if signs of allergic reaction appear.

Avoid Interactions

Ivy leaf extract may interact with certain medicines or substances. The interactions are grouped by the level of concern.

Avoid

  • Concurrent use with potent bronchodilators may increase risk of bronchospasm.
  • Combination with other herbal expectorants containing similar active compounds may potentiate effects.
  • Use together with anticoagulant therapy is not recommended without monitoring.

Use with caution

  • May enhance the effect of antihistamines, leading to increased sedation.
  • Potential additive gastrointestinal effects when taken with NSAIDs.
  • Concurrent use with other hepatically metabolized drugs should be monitored.

Frequently Asked Questions

Helituspan contains a dry extract of Hederae Folium (ivy leaf) standardized at a 5‑7.5:1 ratio and extracted using a 30 % ethanol (m/m) solvent.

The product is intended for oral administration; specific dosage forms are not detailed in the available information.

Helituspan may be considered as an adjunct for occasional non‑productive cough, mild upper‑respiratory irritation, throat discomfort, and to support expectoration.

Helituspan is marketed within the EU, but its prescription status is not clearly defined in the source data.

Commonly reported effects include mild gastrointestinal discomfort, transient skin rash, mild headache, and dizziness.

Serious reactions, although rare, may include allergic anaphylaxis, severe bronchospasm, and occasional hepatic enzyme elevation.

Precautions include checking for ivy allergy, avoiding use in children under 12 without medical advice, exercising caution in asthma or COPD, and consulting a clinician during pregnancy or lactation.

Safety data for children under 12 and for pregnant or breastfeeding women are not established; professional guidance is recommended.

Avoid concurrent use with potent bronchodilators, other herbal expectorants with similar activity, and anticoagulant therapy unless monitored.

Store in a cool, dry place away from direct sunlight and keep the container tightly closed to preserve the extract.

Helituspan may enhance the sedative effect of antihistamines, so use with caution and monitor for increased drowsiness.

Further details may be obtained from the product’s regulatory dossier, the manufacturer’s technical sheet, or national pharmacovigilance databases.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Dry Extract Of Hederae Folium (5-7.5:1), Extraction Solvent: Ethanol 30% (M/M)

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT